Cargando…

The LAC Score Indicates Significant Fibrosis in Patients With Chronic Drug-Induced Liver Injury: A Large Biopsy-Based Study

Currently, there are no satisfactory noninvasive methods for the diagnosis of fibrosis in patients with chronic drug-induced liver injury (DILI). Our goal was to develop an algorithm to improve the diagnostic accuracy of significant fibrosis in this population. In the present study, we retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhong-Bin, Chen, Dan-Dan, He, Qing-Juan, Li, Le, Zhou, Guangde, Fu, Yi-Ming, Deng, Ya, Niu, Xiao-Xia, Chu, Fang, Gao, Xiao-Pan, Zou, Zhengsheng, Chen, Guofeng, Ji, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416439/ https://www.ncbi.nlm.nih.gov/pubmed/34483945 http://dx.doi.org/10.3389/fphar.2021.734090

Ejemplares similares

Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China
por: Zhang, Xiujuan, et al.
Publicado: (2021)

Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis
por: Chen, Chen, et al.
Publicado: (2022)

Effects of public reporting of prescription indicators on patient choices: evidence from propensity scores matching
por: Chen, Manli, et al.
Publicado: (2023)

TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022)

Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
por: Chin, Jun L., et al.
Publicado: (2016)

An Integration of Network Pharmacology and Experimental Verification to Investigate the Mechanism of Guizhi to Treat Nephrotic Syndrome
por: He, Dan, et al.
Publicado: (2021)

Nonclinical safety evaluation of food colorant lac dye via systematic toxicity profiling with assessment of in vivo antigenic potential
por: Park, Jin-Sung, et al.
Publicado: (2022)

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
por: Liu, Zherui, et al.
Publicado: (2023)

Natural Products Against Renal Fibrosis via Modulation of SUMOylation
por: Liu, Peng, et al.
Publicado: (2022)

Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
por: Xu, Jie, et al.
Publicado: (2020)

BMP-7 Upregulates Id2 Through the MAPK Signaling Pathway to Improve Diabetic Tubulointerstitial Fibrosis and the Intervention of Oxymatrine
por: Xiao, Yawen, et al.
Publicado: (2022)

Rhubarb Protect Against Tubulointerstitial Fibrosis by Inhibiting TGF-β/Smad Pathway and Improving Abnormal Metabolome in Chronic Kidney Disease
por: Zhang, Zhi-Hao, et al.
Publicado: (2018)

Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
por: Liu, Xiao-Yuan, et al.
Publicado: (2022)

Chronic Drug-Induced Liver Injury: Updates and Future Challenges
por: Wang, Qiaoling, et al.
Publicado: (2021)

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response
por: Ma, Yun-Long, et al.
Publicado: (2023)

Impact of Adolescent Intermittent Ethanol Exposure on Social Investigation, Social Preference, and Neuronal Activation in cFos-LacZ Male and Female Rats
por: Towner, Trevor T., et al.
Publicado: (2022)

Metabolic reprogramming of pulmonary fibrosis
por: Li, Jiaxin, et al.
Publicado: (2022)

Lipidomics Indicates the Hepatotoxicity Effects of EtOAc Extract of Rhizoma Paridis
por: Li, Chaofeng, et al.
Publicado: (2022)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Editorial: New insights into renal fibrosis and therapeutic effects of natural products volume II
por: Chen, Dan-Qian, et al.
Publicado: (2022)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
por: Huang, He, et al.
Publicado: (2020)

The effect of the cyclic GMP-AMP synthase-stimulator of interferon genes signaling pathway on organ inflammatory injury and fibrosis
por: Liu, Yuliang, et al.
Publicado: (2022)

Genome-wide analysis of the Pleurotus eryngii laccase gene (PeLac) family and functional identification of PeLac5
por: Li, Zihao, et al.
Publicado: (2023)

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology Strategy
por: Zhu, De-wei, et al.
Publicado: (2022)

Lac Felinum
por: Berridge, E. W.
Publicado: (1887)

Lac Caninum
por: Berridge, E. W.
Publicado: (1883)

Lac Vaccinum
por: Swan, S.
Publicado: (1889)

Lac Caninum
por: Berridge, E. W.
Publicado: (1884)

Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291/LEFTY2 Axis
por: Yang, Ya-Ru, et al.
Publicado: (2021)

Circulating galectin-3 promotes tumor-endothelium-adhesion by upregulating ICAM-1 in endothelium-derived extracellular vesicles
por: Wang, Lei, et al.
Publicado: (2022)

Fenofibrate Improves Insulin Resistance and Hepatic Steatosis and Regulates the Let-7/SERCA2b Axis in High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice
por: Zhang, Dan, et al.
Publicado: (2022)

Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances
por: Liu, Li, et al.
Publicado: (2014)

Pharmacodynamic Evaluation and PK/PD-Based Dose Prediction of Tulathromycin: A Potential New Indication for Streptococcus suis Infection
por: Zhou, Yu-Feng, et al.
Publicado: (2017)

Stachydrine Ameliorates Cardiac Fibrosis Through Inhibition of Angiotensin II/Transformation Growth Factor β1 Fibrogenic Axis
por: Liu, Xiao, et al.
Publicado: (2019)

Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy
por: Jiang, Mengjie, et al.
Publicado: (2019)

Fraxin Promotes the Activation of Nrf2/ARE Pathway via Increasing the Expression of Connexin43 to Ameliorate Diabetic Renal Fibrosis
por: Chen, Rui, et al.
Publicado: (2022)

Clinical Indications of Recombinant Human Erythropoietin in a Single Center: A 10-Year Retrospective Study
por: Guan, Xiao-Zhen, et al.
Publicado: (2020)

Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
por: Chen, Xiao-Feng, et al.
Publicado: (2022)

Tibetan Medical Formula Shi-Wei-Gan-Ning-Pill Protects Against Carbon Tetrachloride-Induced Liver Fibrosis – An NMR-Based Metabolic Profiling
por: Feng, Xin, et al.
Publicado: (2018)

Lac-Phe mediates the anti-obesity effect of metformin
por: Xiao, Shuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nnno53sgb3k1lq3gcc55e93snc